Nucleoside analog DFP-10917
Term · Oncology and biomedicine · MLC-T-ONC-015550
A deoxycytosine analog with potential antineoplastic activity. Upon administration, DFP-10917 is phosphorylated to generate its nucleotide form, which functions as a deoxycytosine mimic and is incorporated into DNA in tumor cells. This causes DNA strand breaks during polymerization due to beta-elimination during the fidelity checkpoint, which results in G2/M phase-arrest and tumor cell apoptosis.
| Identifier | MLC-T-ONC-015550 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | CNDAC |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015550",
"term": "Nucleoside analog DFP-10917",
"field": "Oncology and biomedicine",
"definition": "A deoxycytosine analog with potential antineoplastic activity. Upon administration, DFP-10917 is phosphorylated to generate its nucleotide form, which functions as a deoxycytosine mimic and is incorporated into DNA in tumor cells. This causes DNA strand breaks during polymerization due to beta-elimination during the fidelity checkpoint, which results in G2/M phase-arrest and tumor cell apoptosis.",
"synonyms": [
"CNDAC"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/nucleoside-analog-dfp-10917/"
}
Record 12,001 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.